Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Fc (human) IgG1 Control (rec.)
170
CHF
CHF 170.00
In stock
AG-35B-0007-C05050 µgCHF 170.00
AG-35B-0007-20502 x 50 µgCHF 290.00
AG-35B-0007-C500500 µgCHF 720.00
AG-35B-0007-M0011 mgCHF 1'270.00
| Product Details | |
|---|---|
| Product Type | Protein |
| Properties | |
| Source/Host | CHO cells |
| Sequence |
Recombinant Fc portion of human IgG1 (aa 105-330). |
| Crossreactivity | Human |
| MW | ~28kDa (SDS-PAGE) |
| Purity | ≥95% (SDS-PAGE) |
| Endotoxin Content | <0.1EU/μg purified protein (LAL test; Lonza). |
| Concentration | 1mg/ml after reconstitution. |
| Reconstitution |
50µg size: Reconstitute with 50µl sterile water. 500µg size: Reconstitute with 500µl sterile water. 1mg size: Reconstitute with 1000µl sterile water. |
| Formulation | Lyophilized. Contains PBS. |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
After reconstitution, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. PBS containing at least 0.1% BSA should be used for further dilutions. |
| Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
Negative control in experiments with recombinant proteins fused to human IgG1 Fc.
Product References
- Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses: M.K. Tveitaras, et al.; Exp. Cell Res. 359, 257 (2017)
- RANKL signaling sustains primary tumor growth in genetically engineered mouse models of lung adenocarcinoma: J. Faget, et al.; J. Thoracic Oncol. 13, 387 (2017)
- Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis: M. Suzuki, et al.; Allergol. Int. 66, 351 (2017)
- Pseudorabies Virus Infection Causes Downregulation of Ligands for the Activating NK Cell Receptor NKG2D: S. Denaeghel, et al.; Viruses 13, 266 (2021)
Related Products
